{"ticker": {"uuid": "120cdc1c-f7e3-48f0-9374-01eddea26b85", "symbol": "2616", "name": "CStone Pharmaceuticals", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "CStone Pharmaceuticals (SEHK:2616) Expands Sugemalimab Reach As Valuation Questions Linger", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jianxin Yang acquired an additional 331,000 ordinary shares of CStone Pharmaceuticals (HKEX: 2616), valued at approximately HK$1.5366 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQcTdHT3NqMHVCeS15eFVuU2MzcnFBQkdTb2tDR1F1V3R1amtrYlBNUkhtVHdJaXhUTnpxX3I2YWZLTlI4c0xSbGl5QXA1SDV6MURISzNXZDdWTlo4QnhFMTVuTkt2WW5Gc09HYXU3Q1JGQzhlS2xvUUw4enJLMmJMRk1wTFk1VHdKN2gzMmYtRjVYR0EzZ1ptRE5jQmhvc05WdVd5d01mWE84anpfY2c?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CStone Pharmaceuticals CEO, President of R&D and Executive Director Acquires 1.0% More Stock", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenues Not Telling The Story For CStone Pharmaceuticals (HKG:2616)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPd2lQb1diLXNpdWgyY0tiVnBwcGd2MEE2aFVMU2NQeW4tSmFJLVhhTHV4ZF92eW1uMkNLTm40SkZ5UmZIbzV3Z0I1bmt0MmVNRGVGN1B3NTdUQW40eEZ0STUzalpBWnU1b3IzZ1RHM0JUdW1HZWl5MlVvckNqZF9kTmppZmlrbG5TOVFFOXByMkVCTFV1YWdlZnZQTFlxeTZkNVlwQlFNQVFfSDMw?oc=5", "source_name": "Moomoo", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of CStone Pharmaceuticals (HKEX:2616)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTFAtV0RYSXViXzg3bFhrUlQ5S3NpZF9NS1pmb0dPazhsOFNsZF9URGRLX000cFhGcFhKajJtdVNBX2sxMGQ1NVpJdUZmM0szX2RmYXllXzFheWl2MHA4SjVFMTVWXzZPb2JX?oc=5", "source_name": "TradingView", "published_at": "2019-03-02T10:42:19+00:00", "published_display": "02 Mar 2019 10:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "CStone Pharmaceuticals (SEHK:2616) Expands Sugemalimab Reach As Valuation Questions Linger", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jianxin Yang acquired an additional 331,000 ordinary shares of CStone Pharmaceuticals (HKEX: 2616), valued at approximately HK$1.5366 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQcTdHT3NqMHVCeS15eFVuU2MzcnFBQkdTb2tDR1F1V3R1amtrYlBNUkhtVHdJaXhUTnpxX3I2YWZLTlI4c0xSbGl5QXA1SDV6MURISzNXZDdWTlo4QnhFMTVuTkt2WW5Gc09HYXU3Q1JGQzhlS2xvUUw4enJLMmJMRk1wTFk1VHdKN2gzMmYtRjVYR0EzZ1ptRE5jQmhvc05WdVd5d01mWE84anpfY2c?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CStone Pharmaceuticals CEO, President of R&D and Executive Director Acquires 1.0% More Stock", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenues Not Telling The Story For CStone Pharmaceuticals (HKG:2616)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPd2lQb1diLXNpdWgyY0tiVnBwcGd2MEE2aFVMU2NQeW4tSmFJLVhhTHV4ZF92eW1uMkNLTm40SkZ5UmZIbzV3Z0I1bmt0MmVNRGVGN1B3NTdUQW40eEZ0STUzalpBWnU1b3IzZ1RHM0JUdW1HZWl5MlVvckNqZF9kTmppZmlrbG5TOVFFOXByMkVCTFV1YWdlZnZQTFlxeTZkNVlwQlFNQVFfSDMw?oc=5", "source_name": "Moomoo", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of CStone Pharmaceuticals (HKEX:2616)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTFAtV0RYSXViXzg3bFhrUlQ5S3NpZF9NS1pmb0dPazhsOFNsZF9URGRLX000cFhGcFhKajJtdVNBX2sxMGQ1NVpJdUZmM0szX2RmYXllXzFheWl2MHA4SjVFMTVWXzZPb2JX?oc=5", "source_name": "TradingView", "published_at": "2019-03-02T10:42:19+00:00", "published_display": "02 Mar 2019 10:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 5, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 4, "score": 53, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 5.28, "latest_week": "2026-07-10", "one_week_move": -2.6, "four_week_move": 13.1, "twelve_week_move": -47.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.983562, "market_dynamics_buy_signal": false, "relative_strength": -20.740051, "fair_value_gap": 39.6, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 45.4297, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.6% over one week, +13.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 2}, {"label": "\u5bcc\u9014\u725b\u725b", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.6% over one week, +13.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "CStone Pharmaceuticals (SEHK:2616) Expands Sugemalimab Reach As Valuation Questions Linger"}], "updated_at": "2026-07-18T02:13:49.709069+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}